Metabolic diseases, including T2DM, are associated with high vascular permeability due to increases in vascular endothelial growth factor (VEGF, [31]), which may lead to increases in metabolite availability in the diabetic lung. Here, VEGFA is linked to type 2 diabetes mellitus.